OWC Pharmaceutical Research Corp (OWCP)

[Triple9]

From page 10 (my emphasis):

IP-owned developed of new innovative and tested delivery
systems.
• Two products ready to market:
• Sublingual Soluble tablet: replacement of smoking, pain
treatment. more than 10 million potential patients in the approved
MMJ states.
• Topical crème: Treatment for different skin diseases starting with
tested psoriasis. ~8 Million Psoriasis patients US & Canada (2.5% of
population), 3 years potential is 2-4 millions monthly income
(following current market prices)

Anyone have a conservative PPS estimate for $24-48 Million? That's just for psoriasis of course, if approved for other skin conditions we get multiples.

http://www.owcpharma.com/wp-content/uploads/2017/01/OWC-PPT-1-2017-FINAL.pdf